Changes in energy during treatment of depression: an analysis of duloxetine in double-blind placebo-controlled trials

AIMS: The aim of this study was to assess how quickly and effectively duloxetine improves energy compared with placebo in patients with major depressive disorder (MDD). METHODS: Data from 10 randomised, double-blind, placebo-controlled clinical trials examining duloxetine (40–60 mg/day) vs. placebo...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, E, Kato, M, Fujikoshi, S, Wohlreich, M M, Berggren, L, Tokuoka, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682452/
https://www.ncbi.nlm.nih.gov/pubmed/25980552
http://dx.doi.org/10.1111/ijcp.12658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682452/
https://www.ncbi.nlm.nih.gov/pubmed/25980552
http://dx.doi.org/10.1111/ijcp.12658

Ejemplares similares